The findings suggest that BMI and obesity prevalence in the US decreased in 2023 for the first time in more than a decade. The most notable decrease was in the South, which had the highest observed per capita GLP-1RA dispensing rate.

Over one in four (26%) adults and 23.4% of children aged 10-11 years in England are living with obesity, placing huge pressure on the health and care system.

Obesity is a widespread public health challenge in the Middle East. The findings highlight the urgent need for targeted interventions to reduce the cardiovascular risk burden

Results suggest that there are economic benefits associated with HbA1c reduction

GLP-1 Reduces AIC by an average of 2%


‍

Healthcare costs 100% more for obese vs. non-obese employees. A study in the Journal of Managed Care + Specialty Pharmacy found increases in all major categories of medical care for adults with obesity, particularly inpatient services and prescription drug expenditures.

Higher health care costs are associated with excess body weight across a broad range of ages and BMI levels, and are especially high for people with severe obesity.

Obesity is a serious, common, and costly chronic disease. More than 2 in 5 U.S. adults have obesity. See the adult obesity facts, CDC

Weight-loss drugs like Ozempic are in shortage, and telehealth startups are selling “compounded” versions. A WIRED investigation looks at how easy it is to order these meds online.

It’s easier than ever to get prescription drugs online. Should regulators be paying more attention?

Increased hospitalizations resulting from unmanaged events, exposure to unregulated ingredients, and improper medication administration.